Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Globus Medical, Inc. Class A Common Stock (NY:GMED)

59.58 +1.01 (+1.72%)
Official Closing Price Updated: 7:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Globus Medical, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting
From Globus Medical
Via GlobeNewswire
Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference
Monday, March 10, 2025 at 4:30 pm Pacific Time 
From Globus Medical
Via GlobeNewswire
1 Mid-Cap Stock to Target This Week and 2 to Avoid
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today
 
Via Benzinga
Looking Into Globus Medical's Recent Short Interest
 
Via Benzinga
What Analysts Are Saying About Globus Medical Stock
 
Via Benzinga
Here's How Much You Would Have Made Owning Globus Medical Stock In The Last 10 Years
 
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Siyata Mobile Inc. (Nasdaq - SYTA), Bridge Investment Group Holdings Inc. (NYSE - BRDG), Nevro Corp. (NYSE – NVRO), 180 Degree Capital Corp. (Nasdaq – TURN)
From Brodsky & Smith LLC
Via GlobeNewswire
Enovis (ENOV) Q4 Earnings: What To Expect
Medical technology company Enovis Corporation (NYSE:ENOV) will be announcing earnings results tomorrow before market open. Here’s what to expect. 
Via StockStory
Globus Medical (GMED) Q4 2024 Earnings Call Transcript
GMED earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
Globus Medical: Q4 Revenue Tops Forecast
Globus Medical's robust earnings for Q4 2024 were driven by strategic acquisitions and sustained innovation. 
Via The Motley Fool
Earnings Scheduled For February 20, 2025
 
Via Benzinga
$100 Invested In Globus Medical 10 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Analyst Expectations For Globus Medical's Future
 
Via Benzinga
Globus Medical’s (NYSE:GMED) Q4 Sales Beat Estimates
Medical device company Globus Medical (NYSE:GMED) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 6.6% year on year to $657.3 million. The company expects the full... 
Via StockStory
Topics Earnings
Globus Medical Reports Fourth Quarter and Full Year 2024 Results
From Globus Medical
Via GlobeNewswire
Globus Medical (GMED) Q4 Earnings: What To Expect
Medical device company Globus Medical (NYSE:GMED) will be announcing earnings results tomorrow after the bell. Here’s what to expect. 
Via StockStory
Investors should take note of NYSE:GMED, a growth stock that remains attractively priced.
Based on Fundamental Analysis it can be said that NYSE:GMED is a growth stock which is not overvalued. 
Via Chartmill
Top 2 Health Care Stocks That May Crash In February
 
Via Benzinga
Why NYSE:GMED is Poised for High Growth.
A fundamental and technical analysis of (NYSE:GMED): Exploring GLOBUS MEDICAL INC - A (NYSE:GMED)'s high growth characteristics. 
Via Chartmill
Price Over Earnings Overview: Globus Medical
 
Via Benzinga
Why GLOBUS MEDICAL INC - A (NYSE:GMED) qualifies as a high growth stock.
Delving into GLOBUS MEDICAL INC - A (NYSE:GMED)'s high Growth Prospects. 
Via Chartmill
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients
From Globus Medical
Via GlobeNewswire
Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
Stryker Had A Good Year Last Year; Here's How It's Looking For 2025
Reflecting its strong growth, on Monday the Relative Strength (RS) Rating for Stryker stock got an upgrade from 70 to 74. 
Via Investor's Business Daily
16 Analysts Have This To Say About Globus Medical
 
Via Benzinga
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
From Globus Medical
Via GlobeNewswire
The Law Offices of Frank R. Cruz Continues Its Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Inspire Medical's Sleep Innovations Driving Big Gains
Inspire Medical, which makes innovative apnea relief devices, hit a key performance benchmark as its Relative Strength Rating jumped to 81. 
Via Investor's Business Daily
Lantheus Stock Doubled In A Year Amid Wide Use Of Its AI-Enabled Medical Devices
Lantheus Holdings sees its Relative Strength Rating reach the 80-plus level. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.